European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

Crespo-Leiro, Maria G., Anker, Stefan D., Maggioni, Aldo P., Coats, Andrew J., Filippatos, Gerasimos, Ruschitzka, Frank, Ferrari, Roberto, Piepoli, Massimo Francesco +23 more·2016·European Journal of Heart Failure
DOI 10.1002/ejhf.566

Cited by (793)

Items 301–400 of 793

  1. Characteristics and Outcomes of Patients Admitted for Acute Heart Failure in a Single-Centre Study
    Jiří Dokoupil, Juraj Hrečko, Eva Čermáková, Michaela Adamcová, Radek Pudil · 2022 · ESC Heart Failure
  2. Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships
    Qin, Xiwen, Hung, Joseph, Knuiman, Matthew W., Briffa, Tom G., Teng, Tiew-Hwa Katherine, Sanfilippo, Frank M. · 2023 · European Journal of Clinical Pharmacology
  3. Clinical profile of patients with heart failure can predict rehospitalization and quality of life
    Michele Di Mauro, Renata Petroni, Daniela Clemente, Massimiliano Foschi, Fabrizio Costantino Tancredi, Virginia Camponetti, Sabina Gallina, Antonio Maria Calafiore, Maria Penco, Silvio Romano · 2018 · Journal of Cardiovascular Medicine
  4. Heart Failure Prevalence in the General Population: SOBOTA-HF Study Rationale and Design
    Mitja Lainščak, Daniel Omersa, Nataša Sedlar, Stefan D. Anker, Jerneja Farkaš · 2019 · ESC Heart Failure
  5. Comparación de mortalidad pronosticada y mortalidad observada en pacientes con insuficiencia cardiaca tratados en una unidad clínica especializada
    Eduardo Barge‐Caballero, Gonzalo Barge‐Caballero, David Couto‐Mallón, Maria Jesús Paniagua-Martín, Raquel Marzoa‐Rivas, Carmen Naya-Leira, Cristina M. Riveiro-Rodríguez, Zulaika Grille-Cancela, Paula Blanco-Canosa, Javier Muñiz et al. · 2019 · Revista Española de Cardiología
  6. A single educational intervention on heart failure self-care: Extended follow-up from a multisite randomized controlled trial
    Hiba Deek, Samar Noureddine, Dalia Allam, Phillip J. Newton, Patricia Mary Davidson · 2020 · European Journal of Cardiovascular Nursing
  7. Hypertensive Heart Failure in Asia
    Helsi Rismiati, Hae‐Young Lee · 2021 · Pulse
  8. What determines who gets cardiac resynchronization therapy in Europe? A comparison between ESC-HF-LT registry, SwedeHF registry, and ESC-CRT Survey II
    Paolo Gatti, Cecilia Marianne Linde, Lina Benson, Tonje Thorvaldsen, Camilla Normand, Gianluigi Savarese, Ulf Dahlström, Aldo Pietro Maggioni, Kenneth Dickstein, Lars H. Lund · 2023 · European Heart Journal - Quality of Care and Clinical Outcomes
  9. Prognostic impact of a reduction in the fibrosis-4 index among patients hospitalized with acute heart failure
    Daichi Maeda, Yumiko Kanzaki, Kazushi Sakane, Kosuke Tsuda, Kanako Akamatsu, Ryoto Hourai, Takahiro Okuno, Daisuke Tokura, Hitomi Hasegawa, Hideaki Morita et al. · 2023 · Heart and Vessels
  10. A csökkent ejekciós frakciójú szívelégtelenség gyógyszeres kezelésének változása és a prognózisra gyakorolt hatása a hazai gyakorlatban
    Balázs Muk, Dávid Pilecky, Fanni Bánfi‐Bacsárdi, Tamás Péter Füzesi, Tamás G. Gergely, Anna Komáromi, Emese Papp, Mihály Dániel Szőnyi, Zsolt Forrai, Ádám Kazay et al. · 2024 · Orvosi Hetilap
  11. Trends in Premature Mortality Due to Heart Failure by Autonomous Community in Spain: 1999 to 2013
    Lidia Gómez-Martínez, Domingo Orozco‐Beltrán, José A. Quesada, Vicente Bertomeu‐González, Vicente Francisco Gil-Guillén, Adriana López‐Pineda, Concepción Carratalá‐Munuera · 2018 · Revista Española de Cardiología (English Edition)
  12. Extending Survival by Reducing Sudden Death with Implantable Cardioverter-Defibrillators: A Challenging Clinical Issue in Non-Ischaemic and Ischaemic Cardiomyopathies
    Giuseppe Boriani, Vincenzo Livio Malavasi · 2017 · European Journal of Heart Failure
  13. Prevalencia e incidencia de hiperpotasemia en población española con insuficiencia cardiaca con fracción de eyección deprimida: revisión sistemática y relevancia poblacional
    Álvaro Hernáez, Juan F. Delgado, Juan Cinca A, Francisco Fernández‐Avilés, Jaume Marrugat · 2018 · Revista Clínica Española
  14. Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective Study
    Chris J. Kapelios, Maria S. Bonou, Paraskevi Vogiatzi, GEORGE L. TZANIS, Polyxeni Mantzouratou, Lars H. Lund, John D. Barbetseas · 2018 · American Journal of Cardiovascular Drugs
  15. Evidence‐based pharmacotherapies used in the postdischarge phase are associated with improved one‐year survival in senior patients hospitalized with heart failure
    Xiwen Simon Qin, Joseph Hung, Matthew William Knuiman, Tiew‐Hwa Katherine Teng, Tom G. Briffa, Frank Mario Sanfilippo · 2018 · Cardiovascular Therapeutics
  16. Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction
    David Fernández-Vázquez, Andreu Ferrero‐Gregori, Jesus Alvarez Garcia, Inés Gómez Otero, Rafael Vázquez, Juan F. Delgado, Fernando Worner Diz, Alfredo Bardajı́, Pablo García‐Pavía, Antoni Bayés‐Genís et al. · 2020 · Revista Española de Cardiología (English Edition)
  17. Estimated Population Prevalence of Heart Failure with Reduced Ejection Fraction in Spain, According to DAPA-HF Study Criteria
    Anna Camps-Vilaró, Juan F. Delgado, Núria Farré, Helena Tizón‐Marcos, Jesus Alvarez Garcia, Juan Cinca A, Irene Roman Degano, Jaume Marrugat · 2020 · Journal of Clinical Medicine
  18. Acceptance of the disease and sexual functions of patients with heart failure
    Alicja Wiśnicka, Izabella Uchmanowicz, Dorota Dyjakon, Ewelina Cichoń, Remigiusz Szczepanowski, Ewa Anita Jankowska · 2020 · European Journal of Cardiovascular Nursing
  19. HF progression among outpatients with HF in a community setting
    Annamaria Iorio, Federico Rea, Giulia Barbati, Arjuna Scagnetto, Elena Peruzzi, Agnese Garavaglia, Giovanni Corrao, Gianfranco Sinagra, Andrea Di Lenarda · 2018 · International Journal of Cardiology
  20. Prognostic significance of right ventricular dysfunction in patients presenting with acute left-sided heart failure
    Mirna Mamdouh Shaker, Hesham Taha, Hossam Kandil, Heba Magdy Kamal, Hossam A. Mahrous, Ahmed A. Elamragy · 2024 · The Egyptian Heart Journal
  21. Distribution and prognostic impact of different heart failure etiologies in patients with heart failure with mildly reduced ejection fraction
    Tobias Schupp, Alexander Schmitt, Felix Lau, Marielen Reinhardt, Noah Abel, Mohammad Abumayyaleh, Mohamed Ayoub, Kambis Mashayekhi, Muharrem Akin, Jonas Rusnak et al. · 2024 · European Journal of Internal Medicine
  22. Regional Differences in the Epidemiology of Heart Failure
    Jasper Tromp, Tiew‐Hwa Katherine Teng · 2024 · Korean Circulation Journal
  23. Therapeutic Consequences and Prognostic Impact of Multimorbidity in Heart Failure: Time to Act
    Fanni Bánfi‐Bacsárdi, Ádám Kazay, Tamás G. Gergely, Zsolt Forrai, Tamás Péter Füzesi, Laura Fanni Hanuska, Pál Péter Schäffer, Dávid Pilecky, Máté Vámos, Vivien Vértes et al. · 2024 · Journal of Clinical Medicine
  24. Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study
    Huan Wang, Chuang Gao, Magalie Guignard‐Duff, Christian Cole, Christopher Hall, Resham Baruah, Shikta Das, He Gao, Jil Billy Mamza, Chim Choy Lang et al. · 2025 · Heart
  25. EURObservational Research Programme: a bibliometric assessment of its scientific output
    Xavier Rosselló, Albert Massó-van Roessel, Ovidiu Chioncel, Luigi Tavazzi, Roberto Ferrari, Alec S. Vahanian, Chris P Gale, Bogdan Alexandru Popescu, Aldo Pietro Maggioni · 2022 · European Heart Journal - Quality of Care and Clinical Outcomes
  26. Assessment of Malnutrition in Heart Failure and Its Relationship with Clinical Problems in Brazilian Health Services
    Juliana Santos Barbosa, Márcia Ferreira Cândido de Souza, Jamille Oliveira Costa, Luciana Vieira Sousa Alves, Larissa Marina Santana Mendonça de Oliveira, Rebeca Rocha de Almeida, Victor Batista Oliveira, Larissa Monteiro Costa Pereira, Raysa Manuelle Santos Rocha, Ingrid Maria Novais Barros de Carvalho Costa et al. · 2022 · International Journal of Environmental Research and Public Health
  27. Effects of Empagliflozin on Gut Microbiota in Heart Failure with a Preserved Ejection Fraction: The Design of a Pragmatic Randomized, Open-Label Controlled Trial (EMPAGUM)
    Xueqing Guan, Chuan-He Wang, Peng Cheng, Lingyu Fu, Qi‐Jun Wu, Gong Cheng, Lin Guan, Zhi-Jun Sun · 2023 · Drug Design Development and Therapy
  28. HiSorb sorptive extraction for determining salivary short chain fatty acids and hydroxy acids in heart failure patients
    Alessio Lenzi, Denise Biagini, Silvia Ghimenti, Federico Maria Vivaldi, Pietro Salvo, Fabio Di Francesco, Tommaso Lomonaco · 2023 · Journal of Chromatography B
  29. Incremental prognostic value of functional impairment assessed by 6-min walking test for the prediction of mortality in heart failure
    Domenico Scrutinio, Pietro Guida, Maria Teresa La Rovere, Laura Adelaide Dalla Vecchia, Giovanni Forni, Rosa Raimondo, Simonetta Scalvini, Andrea Passantino · 2024 · Scientific Reports
  30. Utilisation of real-world data from heart failure registries in OECD countries - A systematic review
    Xiaoyang Du, Adina Khamitova, Mattias Kyhlstedt, Sun Sun, Mathilde Sengoelge · 2018 · IJC Heart & Vasculature
  31. Relationship of Central Venous Pressure to Body Fluid Volume Status and Its Prognostic Implication in Patients With Acute Decompensated Heart Failure
    Taiki Sakaguchi, Akio Hirata, Kazunori Kashiwase, Yoshiharu Higuchi, Tomohito Ohtani, Yasushi Sakata, Yoshio Yasumura · 2018 · Journal of Cardiac Failure
  32. Predicting the 1-Year All-Cause Mortality After Hospitalisation for an Acute Heart Failure Event: A Real-World Derivation Cohort for the Development of the S2PLiT-UG Score
    Josip A. Borovac, Duška Glavaš, Joško Božić, Katarina Novak · 2019 · Heart Lung and Circulation
  33. Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors
    Helena Norberg, Ellinor Bergdahl, Krister Lindmark · 2019 · Cardiovascular Therapeutics
  34. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold
    Edoardo Sciatti, Lucia Dallapellegrina, Marco Metra, Carlo Lombardi · 2019 · Journal of Cardiovascular Medicine
  35. Mildly Symptomatic Heart Failure with Reduced Ejection Fraction: Diagnostic and Therapeutic Considerations
    Alexandra Arvanitaki, Eleni Michou, Andreas P. Kalogeropoulos, Haralambos I. Karvounis, George A. Giannakoulas · 2020 · ESC Heart Failure
  36. The impact of serum concentration‐guided digoxin therapy on mortality of heart failure patients: A long‐term follow‐up, propensity‐matched cohort study
    Balázs Muk, Máté Vámos, Péter Bógyi, Barna A. Szabo, Miklós Dékány, Dénes Vágány, Zsuzsanna Majoros, Tünde Borsányi, Gábor Zoltán Duray, Róbert Gábor Kiss et al. · 2020 · Clinical Cardiology
  37. Clinical Characteristics and Contemporary Management of Patients With Cardiomyopathies in Japan ― Report From a National Registry of Clinical Personal Records ―
    Nobuyuki Enzan, Shouji Matsushima, Tomomi Ide, Hidetaka Kaku, Takeshi Tohyama, Kouta Funakoshi, Taiki Higo, Hiroyuki Tsutsui · 2021 · Circulation Reports
  38. Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction
    Wei-Ren Lan, Shu-I Lin, Feng‐Ching Liao, Hung‐Yu Chang, Cheng-Ting Tsai, Yih-Jer Wu, Ping‐Yen Liu, Chen-Huan Chen, Ying‐Hsiang Lee · 2021 · The American Journal of Cardiology
  39. ICD-10 code-based definition of heart failure in Saint Petersburg electronic health records: prevalence, health care utilization and outcomes
    A. E. Soloveva, G. V. Endubaeva, N. G. Avdonina, E. I. Kogan, T. V. Gorbacheva, A. V. Lubkovsky, Arkady V. Yazenok, Aleksey N. Yakovlev, Н. Э. Звартау, Виллевальде Светлана Вадимовна et al. · 2021 · Russian Journal of Cardiology
  40. Burden of Hospitalizations in Newly Diagnosed Heart Failure Patients in Poland: Real World Population Based Study in Years 2013–2019
    Przemysław Leszek, Daniel Waś, Kinga Bartolik, Klaudiusz Witczak, A Kleinork, Bohdan J. Maruszewski, Katarzyna Brukało, Paulina Rolska-Wójcik, Małgorzata Celińska‐Spodar, Tomasz Hryniewiecki et al. · 2022 · ESC Heart Failure
  41. Left atrial reverse remodeling improves risk stratification in patients with heart failure with recovered ejection fraction
    Masayuki Shiba, Takao Kato, Takeshi Morimoto, Hidenori Yaku, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Yuta Seko, Erika Yamamoto, Yusuke Yoshikawa et al. · 2022 · Scientific Reports
  42. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin
    Karel Lábr, Jindřich Špinar, Jiří Pařenica, Lenka Špinarová, Filip Málek, Monika Špinarová, Ondřej Ludka, Jiří Jarkovský, Klára Benešová, Monika Pávková Goldbergová et al. · 2018 · Kidney & Blood Pressure Research
  43. Heart Failure Registries: How Far can We Go?
    John Parissis, Dimitrios T. Farmakis, Filippos K. Triposkiadis · 2016 · European Journal of Heart Failure
  44. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
    Cosentino, Francesco, Grant, Peter J, Aboyans, Victor, Bailey, Clifford J, Ceriello, Antonio, Delgado, Victoria, Federici, Massimo, Filippatos, Gerasimos, Grobbee, Diederick E, Hansen, Tina Birgitte et al. · 2020 · European Heart Journal
  45. Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI
    Luis Almenar Bonet, Álvaro González Franco · 2021 · Revista Clínica Española (English Edition)
  46. Prognostic Value of the Severity of Clinical Congestion in Patients Hospitalized for Decompensated Heart Failure: Findings From the Japanese KCHF Registry
    Kenji Aida, Kazuya Nagao, Takao Kato, Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Yodo Tamaki, Erika Yamamoto, Yusuke Yoshikawa, Takeshi Kitai et al. · 2023 · Journal of Cardiac Failure
  47. Effect of low-dose administration of carperitide for acute heart failure: the LASCAR-AHF trial
    Satoshi Honda, Toshiyuki Nagai, Yasuyuki Honda, Hiroki Nakano, Takanori Kawabata, Hirotada Maeda, Koko Asakura, Naotsugu Iwakami, Sakae Takenaka, Yoshiya Kato et al. · 2024 · European Heart Journal Acute Cardiovascular Care
  48. Temporal trends in guideline-recommended medical therapy after an acute heart failure decompensation event: an observational analysis from Generator Heart Failure DataMart
    Renzo Laborante, Agni Delvinioti, Andrada Mihaela Tudor, Jacopo Lenkowicz, Chiara Iacomini, Antonio Iaconelli, Donato Antonio Paglianiti, Mattía Galli, Daniele Rodolico, Stefano Patarnello et al. · 2025 · BMJ Open
  49. Global Registries and Surveys Programme–Heart Failure (GRASP-HF): Rationale, Study Design and Research Implications
    Ovidiu Chioncel, Gianluigi Savarese, Cécile Laroche, Offer Amir, Mariya Petkova Tokmakova, Antonio Nicola Cannata, Doan Loi Do, Tarek A Kafafy, Jan Krejčí, Brenda Moura et al. · 2025 · European Journal of Heart Failure
  50. Palliative Care in Chronic Heart Failure: A Systematic Review of Its Impact on Symptoms, Quality of Life, and Decision-Making Process
    Tatiana Dramba, Andrei Emilian Popa, Mihaela Poroch, Gema Bacoanu, Irina Mihaela Esanu, Elena Popa, Vladimir Poroch · 2025 · Diseases
  51. Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure
    Emi Watanabe-Fujinuma, Hideki Origasa, Luke Bamber, Lothar Roessig, Tetsumi Toyoda, Yuri Haga, Chad J. Gwaltney, Burkert Mathias Pieske · 2020 · Health and Quality of Life Outcomes
  52. Heart Transplantation of the Elderly—Old Donors for Old Recipients: Can We Still Achieve Acceptable Results?
    Moritz Benjamin Immohr, Hug Aubin, Ralf Westenfeld, Sophiko Erbel‐Khurtsidze, I. Tudorache, Payam Akhyari, Artur Lichtenberg, Udo Boeken · 2022 · Journal of Clinical Medicine
  53. The Impact of Specialised Heart Failure Outpatient Care on the Long-Term Application of Guideline-Directed Medical Therapy and on Prognosis in Heart Failure with Reduced Ejection Fraction
    Balázs Muk, Fanni Bánfi‐Bacsárdi, Máté Vámos, Dávid Pilecky, Zsuzsanna Majoros, Gábor Török, Dénes Vágány, Balázs Polgár, Balázs Solymossi, Tünde Borsányi et al. · 2024 · Diagnostics
  54. Adherence to Treatment Guidelines in Ambulatory Heart Failure Patients with Reduced Ejection Fraction in a Latin-American Country: Observational Study of the Colombian Heart Failure Registry (RECOLFACA)
    Alex Arnulfo Rivera-Toquica, Luis Eduardo Echeverría, Carlos Andrés Arias-Barrera, Fernán Mendoza-Beltrán, Diego Hernán Hoyos-Ballesteros, Carlos Andrés Plata-Mosquera, Juan Carlos Ortega-Madariaga, Juan Fernando Carvajal Estupiñán, Viviana Quintero-Yepes, Luz Clemencia Zárate-Correa et al. · 2024 · Cardiology
  55. Cognitive Performance in Late Adolescence and Long-Term Risk of Early Heart Failure in Swedish Men
    Martin Lindgren, Peter Eriksson, Annika Rosengren, Josefina Robertson, Linus Schiöler, Maria Schaufelberger, N. David Åberg, Kjell Torén, Margda Wærn, Maria Åberg · 2018 · European Journal of Heart Failure
  56. Mortality and Heart Failure Hospitalizations. The Need for an Exhaustive, Official, and Standardized Registry
    Josep Lupón, Antoni Bayés‐Genís · 2019 · Revista Española de Cardiología (English Edition)
  57. Ultrasound guidance for volume management in patients with heart failure
    Michael J. Bonios, Stamatis Kyrzopoulos, Dimitris Tsiapras, Stamatis N. Adamopoulos · 2019 · Heart Failure Reviews
  58. Efficacy and safety of non-vitamin K anticoagulants and warfarin in patients with atrial fibrillation and heart failure: A network meta-analysis
    Hao Jin, Kongbo Zhu, Lina Wang, Wangjuan Zhou, Hong Zhi · 2020 · Thrombosis Research
  59. Consenso sobre el manejo de la hiperpotasemia en pacientes con insuficiencia cardíaca: recomendaciones de la SEC-SEMI
    L. Almenar Bonet, Álvaro González Franco · 2021 · Revista Clínica Española
  60. Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support
    Federica Guidetti, Mattia Arrigo, Michelle Frank, Fran Mikulicic, Mateusz Sokolski, Raed Aser, Markus Johannes Wilhelm, Andreas J. Flammer, Frank Thomas Ruschitzka, Stephan H. Winnik · 2021 · Heart Failure Clinics
  61. Temporal trends in characteristics, treatment, and outcomes of heart failure in octogenarians over two decades
    Renata De Maria, Mauro Gori, Marco Marini, Lucio Gonzini, Manuela Benvenuto, Leonarda Cassaniti, Annamaria Municinò, Alessandro Navazio, Enrico Ammirati, Giuseppe Leonardi et al. · 2022 · Revista Española de Cardiología (English Edition)
  62. Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
    Chris J. Kapelios, Lina Benson, María G. Crespo‐Leiro, Stefan D. Anker, Andrew J.S. Coats, Ovidiu Chioncel, Gerasimos S Filippatos, Mitja Lainščak, Theresa A. McDonagh, Alexandre Mebazaa et al. · 2023 · European Heart Journal
  63. Negotiating renal dysfunction when treating patients with heart failure
    Valentina Carubelli, Marco Metra, Lars H. Lund · 2018 · Expert Review of Cardiovascular Therapy
  64. Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term
    María G. Crespo‐Leiro, Eduardo Barge‐Caballero, Javier Segovia, José González‐Costello, Antoni Bayés‐Genís, Silvia López‐Fernández, Sònia Mirabet, Marisa Sanz‐Julve, Carla Fernández‐Vivancos, José María Pérez-Ruiz et al. · 2020 · REC CardioClinics
  65. Patient Outcome after Implant of a Cardioverter Defibrillator in the ‘Real World’: The Key Role of Co-Morbidities
    Giuseppe Boriani, Vincenzo Livio Malavasi · 2017 · European Journal of Heart Failure
  66. Prediction of Cardiac Worsening Through to Cardiogenic Shock in Patients with Acute Heart Failure
    Benedikt Norbert Beer, Caroline Kellner, Jonas Sundermeyer, Lisa Besch, Angela Dettling, Paulus F. Kirchhof, Stefan Blankenberg, Christina Magnussen, Benedikt Schrage · 2024 · ESC Heart Failure
  67. Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)
    Sergey N. Tereshchenko, И. В. Жиров, Tatiana M. Uskach, Marina A. Saidova, Golitsyn Sp, E. M. Rimskaya, Насонова Светлана Николаевна, O. Yu. Narusov, Alfiya A. Safiullina, Andrew S. Tereshchenko et al. · 2024 · Eurasian heart journal
  68. Heart Failure Beyond the Diagnosis: A Narrative Review of Patients’ Perspectives on Daily Life and Challenges
    Michelle Shigi Yang, Mohamed Bilal Abdallah, Zubair Shahid Bashir, Wissam I. Khalife · 2024 · Journal of Clinical Medicine
  69. Association of platelet-to-lymphocyte ratio with 1-year all-cause mortality in ICU patients with heart failure
    Xinyu Hu, Shijiao Cheng, Huaan Du, Yuehui Yin · 2024 · Scientific Reports
  70. Creatinine and NT-ProBNP levels could predict the length of hospital stay of patients with decompensated heart failure
    Raquel López‐Vilella, Elena Marqués‐Sulé, Ignacio José Sánchez-Lázaro, Rocío del Pilar Laymito-Quispe, Luis Martínez‐Dolz, Luis Almenar Bonet · 2021 · Acta cardiologica. Supplementum
  71. Cardiac Contractility Modulation in Patients with Heart Failure with Reduced Left Ventricular Ejection Fraction
    Francesco Giallauria, Alessandro Parlato, Anna Di Lorenzo, Crescenzo Testa, Antonio D’Onofrio, Gianfranco Sinagra, Mauro Biffi, Carlo Vigorito, Andrew J.S. Coats · 2021 · Hearts
  72. Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: Prospective international cohort study
    Benedetta Pongiglione, Aleksandra Torbica, Chris P Gale, Luigi Tavazzi, Panos E. Vardas, Aldo Pietro Maggioni · 2021 · PLoS ONE
  73. Effectiveness and ost-efficacy of iuretics ome dministration via eripherally nserted entral enous atheter in atients with nd- tage eart ailure
    Cosmo Godino, Andrea Scotti, Alessandra Marengo, Ivana Battini, Paola Brambilla, Silvia Stucchi, Massimo Slavich, Anna Salerno, Gabriele Fragasso, Alberto Margonato · 2022 · International Journal of Cardiology
  74. Early prediction of clinical scores for left ventricular reverse remodeling using extreme gradient random forest, boosting, and logistic regression algorithm representations
    Lu Liu, Cen Qiao, Jun-Ren Zha, Huan Qin, Xiaorui Wang, Xinyu Zhang, Yiou Wang, Xiu-Mei Yang, Shu-Long Zhang, Jing Qin · 2022 · Frontiers in Cardiovascular Medicine
  75. One-year rehospitalisation and mortality after acute heart failure hospitalisation: a competing risk analysis
    Irene Marques, Denisa M. Mendonça, Laetitia Teixeira · 2023 · Open Heart
  76. Exploring Regional Disparities in Heart Failure Epidemiology and Outcomes: A Comprehensive Study Across Geographical Regions in Türkiye
    Anıl Şahin, Tuğçe Çöllüoğlu, Ahmet Çelik, Naim Ata, Mehmet Birhan Yılmaz, Dilek Ural, Arzu Kanık, Mustafa Okan Ayvalı, Mustafa Mahir Ülgü, Şuayıp Birinci · 2024 · Balkan Medical Journal
  77. Short-Stay Units vs Routine Admission From the Emergency Department in Patients With Acute Heart Failure
    Peter S. Pang, David A. Berger, Simon A. Mahler, Xiaochun Li, Susan J. Pressler, Kathleen A. Lane, Jason J. Bischof, Douglas Mark Char, Deborah B. Diercks, Alan E. Jones et al. · 2024 · JAMA Network Open
  78. Regional Differences in Heart Failure Hospitalizations, Mortality, and Readmissions in Slovenia 2004–2012
    Daniel Omersa, Ivan Eržen, Mitja Lainščak, Jerneja Farkaš · 2019 · ESC Heart Failure
  79. Favorable five-year outcomes for heart failure diagnosed in younger patients without severe comorbidity
    Christian Madelaire, Finn Gustafsson, Lynne Warner Stevenson, Søren Lund Kristensen, Lars Køber, Julie Andersen, Maria D’Souza, Christian Tobias Torp-Pedersen, Gunnar Gislason, Morten Schou · 2020 · International Journal of Cardiology
  80. The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry
    Zorba Blázquez‐Bermejo, Núria Farré, Marc Llagostera, Pedro Caravaca Pérez, Laura Morán-Fernández, Aleix Fort, Javier de Juan Bagudá, Sonia Ruiz, Juan F. Delgado · 2020 · PLoS ONE
  81. PRADOC: A Trial on the Efficiency of a Transition Care Management Plan for Hospitalized Patients with Heart Failure in France
    Claire Duflos, Jean‐Philippe Labarre, Roxana Ologeanu, Marie Robin, Guillaume Cayla, Michel Galinier, Frédéric Georger, Thibaut Petroni, C Rosario Alarcón, Sylvain Aguilhon et al. · 2020 · ESC Heart Failure
  82. Full-Length Transcriptome Sequencing: An Insight Into the Dog Model of Heart Failure
    Xiaoyan Liang, Zechen Bai, Feifei Wang, Yafan Han, Huaxin Sun, Jiasuoer Xiaokereti, Ling Zhang, Xianhui Zhou, Yanmei Lu, Baopeng Tang · 2021 · Frontiers in Cardiovascular Medicine
  83. Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea
    Kristian Berge, Jon Brynildsen, Ragnhild Røysland, Heidi Strand, Geir Christensen, Arne Didrik Høiseth, Torbjørn Omland, Helge Rørvik Røsjø, Magnus Nakrem Lyngbakken · 2022 · Open Heart
  84. Outcomes with Sacubitril/Valsartan in Outpatients with Heart Failure and Reduced Ejection Fraction: The ARIADNE Registry
    Aldo Pietro Maggioni, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jarosław Dróżdż, Cândida Fonseca, Lars H. Lund, Stefanie Kalus, Philippe C. Ferber, Rizwan Iqbal Hussain et al. · 2022 · ESC Heart Failure
  85. Cardiovascular Consequences of Acute Kidney Injury: Treatment Options
    Jūlija Voicehovska, Dace Trumpika, Vladimirs Voicehovskis, Eva Bormane, Inara Bušmane, Anda Grigane, Eva Moreino, Aivars Lejnieks · 2023 · Biomedicines
  86. Programa MICCAP (Manejo de la Insuficiencia Cardiaca en Cardiología y en Atención Primaria): mejorando el manejo del paciente con insuficiencia cardiaca
    Vivencio Barrios, Carlos Escobar, Vicente Pallarés‐Carratalá, M.I. Egocheaga, José María Lobos, Ramón Bover, J.J. Gómez Doblas, Juan Cosín · 2018 · Medicina de Familia SEMERGEN
  87. Sacubitril/valsartan: from a large clinical trial to clinical practice
    Edoardo Sciatti, Michele Senni, Carlo Lombardi, Mauro Gori, Marco Metra · 2018 · Journal of Cardiovascular Medicine
  88. The impact of worsening renal function with elevated B-type natriuretic peptide at discharge on 1-year prognosis in heart failure patients
    Toshitaka Okabe, Takehiko Kido, Taro Kimura, Tadayuki Yakushiji, Yu Asukai, Suguru Shimazu, Jumpei Saito, Yuji Oyama, Wataru Igawa, Morio Ono et al. · 2020 · Scientific Reports
  89. Identifying congestion phenotypes using unsupervised machine learning in acute heart failure
    Tripti Rastogi, Olivier Huttin, Jozine M. ter Maaten, Guillaume Baudry, Luca Monzo, Emmanuel Bresso, Kévin Duarte, Jasper Tromp, Adriaan A. Voors, Nicolas Girerd · 2025 · European Heart Journal - Digital Health
  90. Extracorporeal veno-venous ultrafiltration in patients with acute heart failure
    Alberto Somaschini, Amanda Casirati, Stefano Cornara, Andrea Demarchi, Alessandro Mandurino Mirizzi, Emmanuel S. Androulakis, Eirini Lioudaki · 2021 · Reviews in Cardiovascular Medicine
  91. A vesefunkció hatása a gyógyszeres terápia optimalizálására és a mortalitásra csökkent ejekciós frakciójú szívelégtelenségben
    Fanni Bánfi‐Bacsárdi, Máté Vámos, Zsuzsanna Majoros, Gábor Török, Dávid Pilecky, Gábor Zoltán Duray, Róbert Gábor Kiss, Noémi Nyolczas, Balázs Muk · 2023 · Orvosi Hetilap
  92. Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry
    Samuela Carigi, Piero Gentile, Mauro Gori, Maria Denitza Tinti, Luisa De Gennaro, Giuseppe Leonardi, Francesco Orso, Anna Rita Felici, Maria Rosaria Catalano, Marina Floresta et al. · 2024 · International Journal of Cardiology
  93. Response by Dauw and Mullens to Letters Regarding Article, “Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study”
    Jeroen Dauw, Wilfried Müllens · 2024 · Circulation Heart Failure
  94. Characteristics and Outcomes of Heart Failure in Japan: A Hospital-Based Administrative Database Analysis
    Yasuhisa Ono, Kazuhiro Yoneda, Naoki Okuyama, Toshiyuki Nagai · 2024 · ESC Heart Failure
  95. Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure
    Yu Horiuchi, Nicholas W. Wettersten, Masahiko Asami, Kazuyuki Yahagi, Kota Komiyama, Hitomi Yuzawa, Jun Tanaka, Jiro Aoki, Kengo Tanabe · 2024 · International Journal of Cardiology
  96. Prevalence and incidence of hyperkalemia in the Spanish population with heart failure with reduced ejection fraction: A systematic review and populational relevance
    Álvaro Hernáez, Juan F. Delgado, Juan Cinca A, Francisco Fernández‐Avilés, Jaume Marrugat · 2018 · Revista Clínica Española (English Edition)
  97. Implantação de dispositivos de ressincronização e/ou desfibrilhação em doentes com insuficiência cardíaca: dados da vida real ‐ o Estudo Síncrone
    Daniel Bonhorst, Sara Lopes Guerreiro, Cândida Fonseca, Nuno Miguel Cardim, Filipe Macedo, Pedro Adragão · 2019 · Revista Portuguesa de Cardiologia
  98. The Association Between Ivabradine and Adverse Cardiovascular Events in Acute Decompensated HFrEF Patients
    Chia‐Te Liao, Jin‐Long Huang, Huai‐Wen Liang, Fa‐Po Chung, Ying‐Hsiang Lee, Po‐Lin Lin, Wei‐Ru Chiou, Wen‐Yu Lin, Chien‐Yi Hsu, Hung‐Yu Chang · 2021 · ESC Heart Failure
  99. Precipitating Factors Leading to Hospitalization and Mortality in Heart Failure Patients
    Abdulla Shehab, Kadhim Sulaiman, Feras Barder, Haitham Amin, Amar M. Salam · 2021 · Heart Views
  100. Vasodilators for acute heart failure—A protocol for a systematic review of randomized clinical trials with meta‐analysis and Trial Sequential Analysis
    Johannes Grand, Olav Wendelboe Nielsen, Jacob Eifer Møller, Christian Hassager, Janus Christian Jakobsen · 2022 · Acta Anaesthesiologica Scandinavica